Biopharmaceuticals, such as hormones and monoclonal antibodies, differ from traditional therapeutics in the sense that they are produced using bacteria, fungi, or other cells. However, the cost for R&D of biopharmaceuticals has been increasing for several years, which slows down the development process. In order to speed up the development of biopharmaceuticals, single-use screening platforms and flexible bioreactor designs are required. In addition, improved techniques, such as perfusion, allow you to maximize your production yields and lower your operating costs. Getinge has the right tools to support the development and production of biopharmaceuticals that enable you to work under GMP conditions.

Chemical synthesis has several disadvantages, such as being unsustainable and requiring large amounts of energy. Instead, numerous bio-chemicals can be produced using microbial fermentation. These bio-chemicals can be used in a wide variety of applications, such as cosmetics, nutrition, and plastics. Development of these new bio-chemicals requires specialized tools in order to make these processes economically viable. The Getinge Applikon bioreactor systems can be adapted to a variety of biochemical product processes with scalable outcomes, in order to support the rapid development of new molecules and increase their marketability.